Pricing Log in Create free account

MDxHealth SA (MDXH) vs ENDRA Life Sciences Inc. (NDRA)

MDxHealth SA and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $14.4M against $7.5M — 1.9× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −32.5%) and the lower return on invested capital (−539.9% vs −23.8%). Across the 15 metrics below, MDxHealth SA leads on 9 and ENDRA Life Sciences Inc. on 6.

Valuation

Metric MDXH NDRA Diagnostics & Research median
P/E n/m n/m 34.52
P/S 0.07 17.21 4.24
P/B n/m 0.98 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 0.81 1.88 5.18
Earnings yield (480.00%) (127.31%) (1.50%)
Free cash flow yield (88.89%) (127.37%) 0.00%

Profitability

Metric MDXH NDRA Diagnostics & Research median
Gross margin 63.23% 0.00% 48.32%
Operating margin (18.04%) 0.00% (5.68%)
Net margin (32.53%) 0.00% (4.10%)
Free cash flow margin (5.24%) 0.00% 0.00%
Return on equity 238.67% (152.04%) 0.00%
Return on assets (27.38%) (110.08%) (6.05%)
Return on invested capital (23.77%) (539.89%) 0.00%

Growth

Metric MDXH NDRA Diagnostics & Research median
Revenue growth (TTM) 21.46% — 8.99%
EPS growth (last fiscal year) 42.24% 84.32% 20.36%
Revenue growth, 5-year CAGR 42.34% — 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXH NDRA Diagnostics & Research median
Debt to equity (3.42) 0.00 0.01
Current ratio 1.15 7.10 2.27
Net debt to EBITDA (10.71) 0.14 0.68

Dividend

Metric MDXH NDRA Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric MDXH NDRA Diagnostics & Research median
Market cap 14.40m 7.51m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack